Today: 30 April 2026
Citigroup stock price slides on fresh layoff plans as Fed week looms
24 January 2026
1 min read

Citigroup stock price slides on fresh layoff plans as Fed week looms

New York, January 23, 2026, 21:29 (EST) — Market closed

  • Citigroup shares dropped 1.8% on Friday, closing at $113.59 and marking a weekly decline.
  • Sources say the bank plans to announce additional layoffs in March, following roughly 1,000 job cuts this month.
  • Citi revealed a $2.5 billion bond redemption set for settlement on Jan. 28.

Shares of Citigroup Inc slipped 1.77% on Friday, ending at $113.59 after hitting a low of $113.22 during the session. The stock heads into next week’s U.S. trading on the defensive.

The decline followed CEO Jane Fraser’s renewed push on cost-cutting. Sources say Citi plans more layoffs in March after cutting around 1,000 jobs this month. CFO Mark Mason told analysts, “We have been reducing headcount and expect that trend to continue,” as the bank’s staff dropped to 226,000 at the end of last year from 240,000 in 2022. Reuters

Citi took action on its balance sheet, announcing it will fully redeem $2.5 billion of its 1.122% fixed-rate/floating-rate notes due in 2027. The redemption will occur on Jan. 28 at par plus accrued interest, part of the bank’s liability management plan focused on funding and capital efficiency.

Friday saw a mixed finish: the Dow dropped 0.58%, but the S&P 500 managed a slight gain of 0.03%, and the Nasdaq climbed 0.28%. Investors shifted gears after a turbulent week.

Policy uncertainty continues to weigh on major consumer lenders like Citi. Bank of America is reportedly exploring new credit cards with a 10% interest rate, while Citi is also considering similar 10% cards in reaction to President Donald Trump’s proposal for a one-year cap on credit card rates, Reuters reported earlier this week; Citi declined to comment.

Citi investors face a straightforward but tricky challenge right now: slash expenses without disrupting operations, keep regulators at bay, and steer clear of policy shocks that could slam consumer lending. Much of this is already baked in after last year’s surge. The stock has been volatile so far in 2026.

The downside scenario is easy to outline. We don’t yet know how deep the March cuts will go or where they’ll hit. High-level layoffs risk shaking up client service and revenue well before any cost savings kick in. On top of that, ongoing Washington scrutiny over card pricing and typical rate sensitivity tighten the margin for error.

Macro factors could dominate soon. With a packed earnings calendar and a Federal Reserve meeting set for next week, market attention has been shifting rapidly. “Earnings are the driver,” said Franklin Templeton strategist Chris Galipeau in a Reuters Week Ahead note. Reuters

The Fed’s two-day meeting is scheduled for Jan. 27–28, with the policy decision set for 2:00 p.m. and a press conference following at 2:30 p.m. on Jan. 28, per the central bank’s calendar.

At Citi, traders are keen to catch any updates on March headcount changes following bonuses, how the bank plans to counter a wider credit card cap, and how the Jan. 28 debt redemption will align with the Fed’s decision.

Stock Market Today

  • Why Investors Are Focused on Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) Amid Growth and High Insider Ownership
    April 29, 2026, 10:29 PM EDT. Vaidya Sane Ayurved Laboratories (NSE:MADHAVBAUG) has attracted investor attention due to its strong financial performance and insider alignment. The company has delivered a compound annual EPS growth of 19% over the past three years, signaling sustained earnings momentum. Revenue growth and an improved EBIT margin, up by 6.6 percentage points to 11%, underscore operational strength. With insiders owning 78% of the firm, alignment between management and shareholders is notably high, reducing agency risk. Valued at ₹2.5 billion, the company appeals to investors favoring profitable, growing firms over speculative ventures without revenue or profit history. This combination of growth, profitability, and insider confidence makes Vaidya Sane a compelling pick in the Ayurvedic healthcare sector.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
GE Vernova stock: Power-unit CEO exit lands days before earnings
Previous Story

GE Vernova stock: Power-unit CEO exit lands days before earnings

Merck (MRK) stock price slips into the weekend — what investors watch next week
Next Story

Merck (MRK) stock price slips into the weekend — what investors watch next week

Go toTop